
|Articles|February 1, 2008
Insomnia drug should be classified under Schedule IV, DEA says
Drug Enforcement Administration proposes placing indiplon in Schedule IV
Advertisement
The Drug Enforcement Administration has proposed placing
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
2
How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025
3
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
4


























































































































































